Asadu Sserwanga
Overview
Explore the profile of Asadu Sserwanga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapisi J, Sserwanga A, Kitutu F, Rutebemberwa E, Awor P, Weber S, et al.
Clin Infect Dis
. 2023 Jul;
77(Suppl 2):S156-S170.
PMID: 37490746
Background: Increasing trends of antimicrobial resistance are observed around the world, driven in part by excessive use of antimicrobials. Limited access to diagnostics, particularly in low- and middle-income countries, contributes...
2.
Kaawa-Mafigiri D, Ekusai-Sebatta D, Rutebemberwa E, Sserwanga A, Kitutu F, Kapisi J, et al.
Clin Infect Dis
. 2023 Jul;
77(Suppl 2):S191-S198.
PMID: 37490741
Background: Antibiotic prescribing practices are 1 of the contributing causes of antimicrobial resistance (AMR). The study explored the key drivers and barriers to adherence to prescribing instructions among healthcare workers...
3.
Ebong C, Sserwanga A, Namuganga J, Kapisi J, Mpimbaza A, Gonahasa S, et al.
Malar J
. 2022 Feb;
21(1):37.
PMID: 35130919
No abstract available.
4.
Kamau A, Paton R, Akech S, Mpimbaza A, Khazenzi C, Ogero M, et al.
BMC Med
. 2022 Jan;
20(1):28.
PMID: 35081974
Background: Understanding the age patterns of disease is necessary to target interventions to maximise cost-effective impact. New malaria chemoprevention and vaccine initiatives target young children attending routine immunisation services. Here...
5.
Okiring J, Epstein A, Namuganga J, Kamya E, Nabende I, Nassali M, et al.
Malar J
. 2022 Jan;
21(1):22.
PMID: 35062952
Background: Routine malaria surveillance data in Africa primarily come from public health facilities reporting to national health management information systems. Although information on gender is routinely collected from patients presenting...
6.
Ebong C, Sserwanga A, Namuganga J, Kapisi J, Mpimbaza A, Gonahasa S, et al.
Malar J
. 2021 Dec;
20(1):484.
PMID: 34952573
Background: In Uganda, artemether-lumefantrine (AL) is first-line therapy and dihydroartemisinin-piperaquine (DP) second-line therapy for the treatment of uncomplicated malaria. This study evaluated the efficacy and safety of AL and DP...
7.
Namuganga J, Briggs J, Roh M, Okiring J, Kisambira Y, Sserwanga A, et al.
Malar J
. 2021 Dec;
20(1):475.
PMID: 34930317
Background: In March 2020, the government of Uganda implemented a strict lockdown policy in response to the COVID-19 pandemic. Interrupted time series analysis (ITSA) was performed to assess whether major...
8.
Namuganga J, Briggs J, Roh M, Okiring J, Kisambira Y, Sserwanga A, et al.
Res Sq
. 2021 Aug;
PMID: 34426808
Background In March 2020, the government of Uganda implemented a strict lockdown policy in response to the COVID-19 pandemic. We performed an interrupted time series analysis (ITSA) to assess whether...
9.
Appiah G, Mpimbaza A, Lamorde M, Freeman M, Kajumbula H, Salah Z, et al.
Am J Trop Med Hyg
. 2021 May;
105(1):37-46.
PMID: 33999850
Invasive Salmonella infection is a common cause of acute febrile illness (AFI) among children in sub-Saharan Africa; however, diagnosing Salmonella bacteremia is challenging in settings without blood culture. The Uganda...
10.
Namuganga J, Epstein A, Nankabirwa J, Mpimbaza A, Kiggundu M, Sserwanga A, et al.
Nat Commun
. 2021 May;
12(1):2635.
PMID: 33976132
The scale-up of malaria control efforts has led to marked reductions in malaria burden over the past twenty years, but progress has slowed. Implementation of indoor residual spraying (IRS) of...